Personalized Medical Care & Dedicated International Patient Concierge
Skin Boosters · Consultation Required
SKINVIVE Skin Booster
SKINVIVE is an injectable skin-hydration treatment made of modified hyaluronic acid that increases moisture within the dermal layer to refine surface smoothness, enhance skin radiance, and soften fine lines without adding facial volume.
Schedule a Consultation
Medically reviewed by Dr. Choi Ji Eun, Director, Toxnfill Hongdae
SKINVIVE is an injectable skin-hydration treatment made of modified hyaluronic acid that increases moisture within the dermal layer to refine surface smoothness, enhance skin radiance, and soften fine lines without adding facial volume. At Toxnfill Hongdae in Seoul, treatment is overseen by Director Dr. Choi Ji Eun, whose clinical focus centers on aesthetic injectable treatments.
What Is SKINVIVE Skin Booster?
- SKINVIVE uses a modified hyaluronic acid formulation delivered as small, numerous injections spaced closely across the treatment area — a microdroplet technique.
- The product is delivered by JUVÉDERM® (Allergan Aesthetics) and received FDA approval in the United States in May 2023 as the first hyaluronic acid microdroplet injectable approved to improve skin smoothness of the cheeks.
- The FDA approval covers all Fitzpatrick Skin Types (I–VI) in patients aged 21 and older.
- The injectable gel contains a small amount of local anesthetic (lidocaine) to help manage injection comfort.
- The clinic describes SKINVIVE as replenishing the skin from within, with a promotional emphasis on a dewy, luminous glow.
- Because SKINVIVE is designed to hydrate rather than add volume, it is positioned as a distinct category from traditional dermal fillers, which are intended to reshape or augment facial contours.
Who Performs SKINVIVE Skin Booster at Toxnfill Hongdae
Dr. Choi Ji Eun, Director at Toxnfill Hongdae, is a graduate of Seoul National University College of Medicine who completed her internship at Seoul National University Hospital. Her documented core specializations include aesthetic medicine and aesthetic injectable treatments, with particular focus on dermal fillers, botulinum toxin, and aesthetic laser and skin treatments — the general treatment category SKINVIVE Skin Booster belongs to. The clinician generally reviews the patient's skin concerns, medical history, medications, allergies, and treatment goals before assessing whether SKINVIVE is appropriate.
Who Is a Good Candidate for SKINVIVE Skin Booster?
- Adults concerned about skin dryness, uneven texture, roughness, or reduced skin quality who want improved hydration without added facial volume.
- Patients seeking a more luminous, smoother-looking complexion via a minimally invasive, non-surgical treatment.
- Patients with active skin infection or inflammation at the treatment site, relevant allergies, or certain medical conditions may not be suitable — final suitability is determined by a clinician.
- Suitability is assessed through consultation covering medical history, medications, allergies, and treatment goals.
What to Expect: Procedure, Recovery, and Results Timeline

- Consultation. The clinician reviews skin concerns, medical history, medications, allergies, and expectations.
-Preparation. The skin is assessed and cleansed before treatment.
-Treatment. The SKINVIVE gel is administered through small, closely spaced injections into the selected treatment areas using the microdroplet technique.
-Aftercare. Patients are advised on avoiding unnecessary pressure or touching of treated areas and following any specific clinic instructions.
Recovery is generally short, although temporary redness, swelling, or bruising may occur for several days depending on the individual. Skin appearance may improve progressively after treatment, with duration of results varying between individuals depending on skin condition and treatment protocol; manufacturer data describe results lasting up to 6 months with an optimal treatment course.
Combining SKINVIVE Skin Booster with Other Treatments
SKINVIVE may be combined with other aesthetic treatments when clinically appropriate, alongside other skin-booster options offered at the clinic including Rejuran, Letigen, Juvelook, and Adite, but the suitable combination and treatment sequence should be decided by the treating clinician based on the patient's specific skin concerns.
Safety, Precision, and Clinic Standards
- Toxnfill Hongdae is a Registered Medical Institution for Attracting Foreign Patients, certified by Korea's Ministry of Health and Welfare under the Medical Overseas Expansion and Foreign Patients Attraction Act.
- SKINVIVE by JUVÉDERM® received US FDA approval on May 15, 2023 as the first FDA-approved hyaluronic acid microdroplet injectable for improving cheek skin smoothness, and the FDA subsequently approved an expanded indication for neck wrinkles in adults 21 and older in June 2026.
- The manufacturer-reported approval covers all Fitzpatrick Skin Types (I–VI), reflecting a broad clinical safety dataset across skin tones.
- Reported risks with injectable skin-booster treatment can include temporary redness, swelling, tenderness, bruising, or small bumps; rare complications can include infection or inflammatory reactions requiring medical evaluation.
- Appropriate patient assessment, sterile microdroplet technique, and qualified medical administration are standard risk-reduction measures for this treatment category.
- The FDA review process for SKINVIVE included clinical trial data supporting both its safety profile and its specific indication for skin smoothness, distinguishing it from unregulated or off-label injectable products on the broader skin-booster market.
The Bottom Line
- SKINVIVE is an FDA-approved hyaluronic acid microdroplet injectable designed to improve skin hydration and smoothness without adding facial volume.
- The formulation includes lidocaine to help manage injection comfort during the microdroplet technique.
- Recovery is generally short, with temporary redness, swelling, or bruising possible for several days.
- Manufacturer data describe results lasting up to 6 months with an optimal treatment course.
- Care is overseen by Director Dr. Choi Ji Eun, whose clinical focus is aesthetic injectable treatments.
Frequently Asked QuestionsIs SKINVIVE Skin Booster painful? The injectable gel contains a small amount of local anesthetic (lidocaine) to help manage comfort during the microdroplet injection technique.** Is SKINVIVE FDA-approved?** Yes — SKINVIVE by JUVÉDERM® received US FDA approval in May 2023 for cheek skin smoothness, with an expanded neck-wrinkle indication approved in June 2026.** When will I see results?** Skin appearance may improve progressively after treatment as the hyaluronic acid increases hydration within the dermal layer; individual timelines vary by skin condition.** How long do results last?** Manufacturer data describe results lasting up to 6 months with an optimal treatment course; individual duration depends on skin condition and treatment protocol.** What should I avoid after treatment?** Avoid unnecessary pressure or touching of treated areas, and temporarily avoid activities that may increase irritation as advised by the clinician.** Who will perform my treatment?** SKINVIVE Skin Booster at Toxnfill Hongdae is overseen by Director Dr. Choi Ji Eun, whose clinical focus is aesthetic injectable treatments; the treatment plan is customized at consultation.** Is SKINVIVE suitable for all skin tones?**
The FDA approval for SKINVIVE by JUVÉDERM® covers all Fitzpatrick Skin Types (I–VI), meaning it has been evaluated across a broad range of skin tones as part of the approval's clinical trial data.
Book a Consultation at Toxnfill Hongdae

To discuss whether SKINVIVE Skin Booster suits your skin and goals, contact Toxnfill Hongdae in Seoul's Hongdae/Mapo-gu district. The clinic is open weekdays 10:30–21:00 and weekends 10:00–17:00 (Korea Standard Time). Enquiries can be made through the clinic's contact page via our online inquiry form. Patient experiences with this and other treatments can be reviewed on the clinic's reviews page.
Disclaimer
This page is for general informational purposes and does not constitute individualized medical advice. Candidacy, technique, and expected outcomes can only be determined through a consultation with a qualified physician.
Sources & Further Reading
- Juvéderm Skinvive Microdroplet Injectable Receives FDA Approval — American Board of Cosmetic Surgery
- SKINVIVE by JUVÉDERM® Receives U.S. FDA Approval — PR Newswire
Clinical Notice: Individual treatment outcomes and recovery timelines may vary depending on skin condition and personal physiology. Temporary redness, mild swelling, or bruising may occur after treatment; a pre-procedure physician consultation is always conducted.
Other Services
Explore additional treatments offered by our specialists.
Cryo Iontzyme Skin Treatment
Cryo Iontzyme Skin Treatment is a non-invasive treatment that combines cooling technology with ion-based delivery to support skin hydration, texture, and overall appearance.
Learn More
Juvelook Skin Booster
Juvelook Skin Booster combines Poly-D,L-Lactic Acid (PDLLA) with hyaluronic acid, micro-injected into the dermal layer to stimulate the skin's own collagen production while restoring volume and improving overall texture.
Learn More
Skin & Pore Botox
Skin & Pore Botox is a botulinum toxin treatment designed for skin texture rather than large muscle groups, delivered through multiple small intradermal injections into areas such as the butterfly zone/cheek where pores and oiliness ar...
Learn More